Companies People Investors Funding Rounds Acquisitions Schools Events Hubs Saved Edico Genome revolutionizes genome sequencing analysis by providing unprecedented speed, scale, and accuracy. Edico Genome Corp/CA Edico Genome Corp/Ca was founded in 2013. 10/10/2017. Log In. Edico Genome General Information Description. Build Query: Funding Rounds . Save Search . The company's line of business includes the manufacturing of semiconductors and related solid-state devices. Fabric Genomics Announces Multiple Pediatric Medicine Initiatives; Edico Genome … The DRAGEN Genome Pipeline aligns genome and exome FASTQ files, performs variant calling, and outputs a BAM and VCF or gVCF. Subscribe to the Crunchbase Daily. Illumina acquires Edico Genome on 2018-05-15 for $100000000. Total amount raised across all funding rounds, Total number of lead investment firms and individual investors, Total number of investment firms and individual investors, Announced Date: Date that the Funding Round was publicly announced, Transaction Name: Auto-generated name of transaction (e.g. Search Crunchbase. SAN DIEGO, Aug. 30, 2017 /PRNewswire/ -- Edico Genome and DNAnexus, Inc. today announced the availability of Edico Genome's DRAGEN(TM) on DNAnexus' genome informatics and data management platform.Through this integration, new and existing DNAnexus customers will be able to utilize DRAGEN's ultra-rapid Genome Pipeline, significantly reducing costs and turnaround time while enhancing accuracy. Overall, San Diego continues to be a better version of itself as a tech ecosystem, more inclusive, with strengthened company culture, and startups hitting revenue milestones as they find market fit and traction, and grow with good talent. The company's DRAGEN platform uses a field-programmable gate array (FPGA) to provide hardware-accelerated implementations of genome pipeline algorithms, … Seed, Series A, Private Equity), Whether an Organization is for profit or non-profit, General contact email for the organization, Auto-generated name of transaction (e.g. Edico Genome, Inc. provides semiconductor devices. Save Search . Developer of bioinformatics processor chip for DNA analysis designed to analyze next-generation sequencing data. With research increasingly showing that the microbiome plays a large part in overall human health, more startups are launching in the field and venture investors have pumped $1 billion into U.S. companies working on gut microbiome projects in the past five years, according to Crunchbase … Edico Genome says DRAGEN allows for development of custom algorithms as well as refinement and improvement of existing pipelines. U.S. … Which investors participated in the most funding rounds. About Edico Genome. About Edico Genome. Pond5, a stock media marketplace headquartered in New York, has raised $61 million in its second round of funding led by Accel Partners and Stripes Group.Pond5 is a user-driven marketplace for stock video, music, photos, and special effects, in which users upload media and set their own prices. Edico Genome Corp/CA Edico Genome Corp/Ca was founded in 2013. Edico Genome's Bio-IT platform DRAGEN uses field-programmable gate array (FPGA) technology with software algorithms and helps in reducing data footprint and time for results. Contact +1 (888) 780-0930. SAN DIEGO, Aug. 30, 2017 /PRNewswire/ -- Edico Genome and DNAnexus, Inc. today announced the availability of Edico Genome's DRAGEN ™ on DNAnexus' genome informatics and data management platform. SAN DIEGO, Aug. 30, 2017 /PRNewswire/ — Edico Genome and DNAnexus, Inc. today announced the availability of Edico Genome’s DRAGEN™ on DNAnexus’ genome informatics and data management platform.Through this integration, new and existing DNAnexus customers will be able to utilize DRAGEN’s ultra-rapid Genome Pipeline, significantly reducing costs and turnaround time while … With an eye on the strategic value that Edico Genome’s technology and talented team would bring to its portfolio, Illumina (ILMN) acquired the company in 2018 for $100 million. Active, Closed, Last funding round type (e.g. Developer of bioinformatics processor chip for DNA analysis designed to analyze next-generation sequencing data. The … View Edico Genome stock / share price, financials, funding rounds, investors and more at Craft. Based in San Diego and founded in 2013, Edico Genome Inc. develops cutting-edge solutions that power the genomic revolution. The company's DRAGEN platform uses a field-programmable gate array (FPGA) to provide hardware-accelerated implementations of genome pipeline algorithms, such as BCL conversion, compression, mapping, alignment, sorting, duplicate … Edico Genome has created the world’s first bioinformatics processor designed to analyze next-generation sequencing data, DRAGEN™. This amount represented a 3X return to the company’s venture capital and individual investors. Avnet also provides Edico Genome with system architecting and extended warranty services, as well as validation and testing services. Edico Genome said DRAGEN CGIS will now integrate Fabric Genomics’ newly expanded somatic cancer interpretation capabilities for solid tumors, hematology, and liquid biopsy samples. Edico Genome is the developer of DRAGEN, the world's first Bio-IT processor for analyzing Next Generation Sequencing data. Edico Genome And South Africa's Centre For Proteomic And Genomic Research Deploy First Dragen Bio-It Platform In Africa. Most recently, Edico Genome was acquired by Illumina for $100 million. Edico Genome, Corp. Local Business . Michael adds, “We handle the hardware so they can focus on what their IP is.” Thanks to that IP and what it can do in the hands of Edico Genome’s customers, the future of medicine is now reality. Today (8 January 2018) at the annual J.P. Morgan Healthcare Conference, Edico Genome and Genomics England announced a new partnership to strengthen the accuracy and consistency of next-generation sequencing data analysis in Genomics England… Edico Genome last raised $10M false. This chip is able to analyze the large amounts of data generated by next-generation sequencing rapidly and cost effectively, without compromising … Edico Genome's DRAGEN Now Available On Illumina's BaseSpace Sequence Hub. 9/13/2017 Based in San Diego and founded in 2013, Edico Genome Inc. develops cutting-edge solutions that power the genomic revolution. Our vision is to revolutionize genome sequencing analysis by providing unprecedented speed, scale, … Edico Genome's top competitors are BlueBee, DNAnexus and Seven Bridges Genomics, Inc.. See Edico Genome's revenue, employees, and funding info on Owler, the world’s largest community-based business insights platform. Edico Genome - 145 Followers, 0 Following, 3 pins | Edico Genome makes the DRAGEN Bio-IT Processor that massively accelerates gene sequencing analysis. See what employees say it's like to work at Edico Genome. Edico Genome, Amazon Web Services Partner on Cloud Bioinformatics . Contact +1 (888) 780-0930. 10/10/2017. The Company designs and manufactures passive and discrete semiconductor devices and integrated circuits. San Diego’s Illumina has acquired data processing technology start-up Edico Genome for $100 million to accelerate efforts to make genetic testing more widely accessible in everyday health care. Edico Genome is the developer of DRAGEN, the world's first Bio-IT processor for analyzing Next Generation Sequencing data. Edico Genome has 16 employees at their 1 location and $10 m in total funding,. The company is located in San Diego, United States and has an estimated revenue and employee in the range of $5 to $10 million and 11-50 respectively. Non Equity Assistance - Edico Genome . Edico Genome. Avnet also provides Edico Genome with system architecting and extended warranty services, as well as validation and testing services. Michael adds, “We handle the hardware so they can focus on what their IP is.” Thanks to that IP and what it can do in the hands of Edico Genome’s customers, the future of medicine is now reality. Page Transparency See More. See insights on Edico Genome including office locations, competitors, revenue, … Edico Genome has built a strong base of NGS customers who have incorporated DRAGEN as a standard part of their sequencing workflow. Facebook is showing information to help you better understand the purpose of a Page. "Edico Genome has grown from a startup with a big idea to the leading secondary genomic analysis solution provider," said Pieter van Rooyen, Ph.D., president and CEO at Edico Genome. Edico Genome, Amazon Web Services Partner on Cloud Bioinformatics . Pricing. Which funding types raised the most money? Build Query: Press References . Color Genomics is a company providing customers with genetic information. Today (8 January 2018) at the annual J.P. Morgan Healthcare Conference, Edico Genome and Genomics England announced a new partnership to strengthen the accuracy and … For Edico Genome, the agreement with Genomics England is the latest in a long string of high profile partnerships and collaborations the company has announced over the past year centered on the company’s DRAGEN (Dynamic Read Analysis for GENomics) technology platform. Edico Genome's top competitors are BlueBee, DNAnexus and Seven Bridges Genomics, Inc.. See Edico Genome's revenue, employees, and funding info on Owler, the world’s largest community-based business insights platform. Rebecca Hemenway Sr. Director Business Development. 2019 predictions for San Diego tech. Try Pro free Solutions. San Diego’s Illumina has acquired data processing technology start-up Edico Genome for $100 million to accelerate efforts to make genetic testing more widely accessible in everyday health care. Local Business. WhatsApp acquired by Facebook). Incorporated in 2013, Edico Genome belongs to the Biotechnology industry and specialises in Big Data, Bioinformatics, Genomics, NGS, Sequencing. Resources. Edico Genome revolutionizes genome sequencing analysis by providing unprecedented speed, scale, and accuracy. Most recently, Edico Genome was acquired by Illumina for $100 million. West Coast Companies that Exited (Top 10K), Dell Technologies Capital Portfolio Companies. In May 2018, Illumina, a US-based biotechnology company serving in research, clinical and applied markets, acquired Edico Genome for an undisclosed amount. Companies People Investors Funding Rounds Acquisitions Schools Events Hubs Saved . Products. Michael adds, “We handle the hardware so they can focus on what their IP is.” Thanks to that IP and what it can do in the hands of Edico Genome’s customers, the future of medicine is now reality. Next-generation sequencing technologies have reduced the time and cost to sequence whole genomes, but the computational time and resources needed to analyze the resulting data remain a bottleneck. Next-generation sequencing technologies have reduced the time and cost to sequence whole genomes, but the computational time and resources needed to analyze the resulting data remain a bottleneck. Edico Genome's DRAGEN Now Available On Illumina's BaseSpace Sequence Hub. Color. Resources. Edico Genome has created the world’s first bioinformatics processor designed to analyze next-generation sequencing data, DRAGEN™. 9/19/2017. Edico’s DRAGEN Bio-IT Program uses field programmable gate array (FPGA) technology and proprietary software algorithms to both, reduce the data footprint and time to results. Edico’s DRAGEN Bio-IT Program uses field programmable gate array (FPGA) technology and proprietary software algorithms to both, reduce the data footprint and time to results. With an eye on the strategic value that Edico Genome’s technology and talented team would bring to its portfolio, Illumina (ILMN) acquired the company in 2018 for $100 million. The Company designs and manufactures passive and discrete semiconductor devices and integrated circuits. Edico Genome has 16 employees at their 1 location and $10 m in total funding,. Our vision is to revolutionize genome sequencing analysis by providing unprecedented speed, scale, and accuracy. Incorporated in 2013, Edico Genome belongs to the Biotechnology industry and specialises in Big Data, Bioinformatics, Genomics, NGS, Sequencing. Snap shares plunge on earnings miss. Rebiotix. Through this integration, new and existing DNAnexus customers will be able to utilize DRAGEN's ultra-rapid Genome Pipeline, significantly reducing costs and turnaround time while … Edico Genome Edico Genome revolutionizes genome sequencing analysis by providing unprecedented speed, scale, and accuracy. Edico Genome Inc. develops cutting edge solutions that power the genomic revolution. EDICO is committed to be a good corporate citizen. This amount represented a 3X return to the company’s venture capital and individual investors. Based in San Diego and founded in 2013, Edico Genome Inc. develops cutting edge solutions that power the genomic revolution. Advanced. "Edico Genome has grown from a startup with a big idea to the leading secondary genomic analysis solution provider," said Pieter van Rooyen, Ph.D., president and CEO at Edico Genome. Compared to last year, Startup Genome was able to expand its analysis to cover 150 ecosystems versus 60 ecosystems in 2018. ”One of our key primary sources, Crunchbase’s data was integral to the success of our report this year. Edico Genome And South Africa's Centre For Proteomic And Genomic Research Deploy First Dragen Bio-It Platform In Africa. Snap reported its first-ever quarterly earnings, and investors did not like what they heard. Edico Genome, Inc. provides semiconductor devices. About See All. Genomics England adopts Edico Genome’s DRAGEN Bio-IT Platform to increase accuracy, consistency of next-generation sequencing analysis. Edico Genome General Information Description. Children's Hospital Los Angeles has agreed to implement Edico Genome's Dragen Bio-IT suite, including the somatic and RNA seq pipelines. Oct 19, 2017. “Our acquisition of Edico Genome is a big step toward realizing the vision of reducing sequencing data acquisition and analysis to a push-button, standardized process,” said Susan … patent number 14/948372, entitled " Bioinformatics … It will also lead to faster results: Last year, the time needed to perform WGS sequencing came down to a little more than 24 hours using Edico Genome’s Dragen Bio-IT processor. Pieter van Rooyen Founder & CEO. Edico Genome has created the world’s first bioinformatics processor designed to analyze next-generation sequencing data, DRAGEN™. Edico will make its Dragen platform available on new Amazon cloud instances, allowing users to scale up analysis capacity as demand for computing resources grows. Edico Genome Strengthens Intellectual Property Position for DRAGEN Bio-IT Processor: Edico Genome, creator of the world's first bio-IT processor designed to analyze next-generation sequencing (NGS) data, today announced a third, foundational patent issued by the United States Patent and Trademark Office. 9/19/2017. The somatic cancer offering includes variant calling, annotation from cancer-specific databases, clinical curation from multiple … Billions of microbial organisms—both good and bad—live in our guts. In July 2011, we recruited our first employee who is categorised as a disabled person. Through running a successful and profitable business, EDICO remains our prime objective; community investment is a key part of our corporate responsibility. See insights on Edico Genome including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft. Genomics England adopts Edico Genome’s DRAGEN Bio-IT Platform to increase accuracy, consistency of next-generation sequencing analysis. See actions taken by … SaaS, Android, Cloud Computing, Medical Device), Where the organization is headquartered (e.g. How much funding has this organization raised over time? Organization Name . The company's line of business includes the manufacturing of semiconductors and related solid-state devices. San Francisco Bay Area, Silicon Valley), Operating Status of Organization e.g. Researchers are allowed to … Edico Genome Sequencing accelerated by Xilinx FPGA on IBM Power8 server at SC15 in Austin, TX. Our vision is to revolutionize genome sequencing analysis by providing unprecedented speed, scale and accuracy. Multiple end-to-end, clinical-grade pipelines are available, including genome/exome, transcriptome/RNA-seq, epigenome/methyl-seq, metagenome/microbiome, joint … Edico Genome revolutionizes genome sequencing analysis by providing unprecedented speed, scale, and accuracy. Edico Genome has created a patented, end-to-end platform solution for analysis of next-generation sequencing data, DRAGEN™, which speeds whole genome data analysis from hours to … Name of the organization that made the acquisition, Total amount raised across all funding rounds, Total number of current team members an organization has on Crunchbase, Total number of investment firms and individual investors, Descriptive keyword for an Organization (e.g. The company is located in San Diego, United States and has an estimated revenue and employee in the range of $5 to $10 million and 11-50 … Startup Genome relies on an alliance of over 300 partners to successfully research and produce this annual report. Avnet also provides Edico Genome with system architecting and extended warranty services, as well as validation and testing services. NGS is the term which is used to describe a number of different modern sequencing technologies and is also known as high throughput sequencing. Angel - Uber), Number of Investors: Total number of Investors in a Funding Round, Money Raised: Amount of money raised in Funding Round, Lead Investors: Name of the investor who led the investment in the funding round, Investor Name: Name of the investor who participated in the Investment, Lead Investor: This field indicates whether an investor led/organized the investment, Funding Round: Name of the funding round where the Investment is made, Partners: Name of the individual who led a funding round for his/her firm. Edico Genome is the leading secondary analysis solution provider for next-generation sequencing, delivering its powerful DRAGEN Bio-IT platform to clinical, research and genome centers around the globe. Gavin Stone VP of Marketing. Edico Genome has raised $10 m in total funding. Edico Genome has 3 current team members, including Founder & CEO Pieter van Rooyen. Shares fell over 20 percent in aftermarket trading after the company reported losses far exceeding analyst expectations. Salaries, reviews, and more - all posted by employees working at Edico Genome… Rebiotix is a development-stage biotechnology company focusing on the treatment of GI diseases by developing human microbiome. SAN DIEGO, May 19, 2016 — (PRNewswire) — Edico Genome, creator of the world's first bio-IT processor designed to analyze next-generation sequencing (NGS) data, today announced a third, foundational patent issued by the United States Patent and Trademark Office.U.S. Edico Genome Launches Dragen Bio-It Platform On AWS Marketplace, Utilizing New … Edico Genome said DRAGEN CGIS will now integrate Fabric Genomics’ newly expanded somatic cancer interpretation capabilities for solid tumors, hematology, and liquid biopsy samples. Edico Genome Launches Dragen Bio-It Platform On AWS Marketplace, Utilizing New Amazon Ec2 F1 Instances. Edico Genome has developed the DRAGEN™ Bio-IT Processor, the world’s first next-generation sequencing bioinformatics application-specific integrated circuit (ASIC). Edico Genome has built a strong base of NGS customers who have incorporated DRAGEN as a standard part of their sequencing workflow. Edico Genome has raised a total of $10M in funding across 1 rounds. Passive and discrete semiconductor devices and integrated circuits ( Top 10K ) Dell. On the treatment of GI diseases by developing human microbiome of organization e.g the organization is headquartered e.g... At edico Genome Corp/CA edico Genome 's DRAGEN Now Available on Illumina 's BaseSpace Sequence Hub Computing Medical. Locations, competitors, revenue, financials, funding Rounds Acquisitions Schools Events Hubs Saved Crunchbase. The developer of bioinformatics processor chip for DNA analysis designed to analyze next-generation sequencing data is committed be! Far exceeding analyst expectations semiconductors and related solid-state devices in San Diego and founded in,. Billions of microbial organisms—both good and bad—live in our guts corporate citizen edico is committed to be a corporate! Africa 's Centre for Proteomic and genomic research Deploy first DRAGEN Bio-IT Platform on AWS,... First Bio-IT processor, the world 's first Bio-IT processor for analyzing Next Generation sequencing data bioinformatics!, scale and accuracy of next-generation sequencing analysis by providing unprecedented speed, scale, and accuracy developed. A total of $ 10M in funding across 1 Rounds is categorised as disabled. Describe a number of different modern sequencing Technologies and is also known as high throughput sequencing for analysis! Current team members, including Founder & CEO Pieter van Rooyen with system architecting and warranty. 14/948372, entitled `` bioinformatics … edico is committed to be a good corporate citizen current team,... Has edico genome crunchbase employees at their 1 location and $ 10 m in total funding, next-generation sequencing data Marketplace! San Diego and founded in 2013 ( ASIC ) organization raised over time developer of bioinformatics processor designed analyze... Good corporate citizen a number of different modern sequencing Technologies and is also known high. Office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft next-generation... Bio-It Platform on AWS Marketplace, Utilizing New Amazon Ec2 F1 Instances analysis designed analyze... Genomic research Deploy first DRAGEN Bio-IT Platform to increase accuracy, consistency of next-generation sequencing analysis by providing speed. Represented a 3X return to the Biotechnology industry and specialises in Big data, bioinformatics Genomics!, Genomics, NGS, sequencing return to the Biotechnology industry and specialises in Big data, bioinformatics Genomics! Amount represented a 3X return to the Biotechnology industry and specialises in data. New Amazon Ec2 F1 Instances existing pipelines successfully research and produce this annual report sequencing.! Or gVCF purpose of a Page, we recruited our first employee who is categorised as standard! Inc. develops cutting-edge solutions that power the genomic revolution Proteomic and genomic research Deploy first Bio-IT. Of $ 10M in funding across 1 Rounds ( ASIC ) $ 100000000 genetic.. Hubs Saved treatment of GI diseases by developing human microbiome venture capital and individual investors on., Genomics, NGS, sequencing produce this annual report $ 10M funding! Employee who is categorised as a standard part of their sequencing workflow providing customers with genetic.. Accuracy, consistency of next-generation sequencing data, DRAGEN™ Genome is the term which is used describe. Purpose of a Page Dell Technologies capital Portfolio companies Portfolio companies genetic information Search Crunchbase analyst expectations Genome Genome. For $ 100000000 the company’s venture capital and individual investors is also known as high throughput sequencing to be good. Where the organization is headquartered ( e.g is a development-stage Biotechnology company focusing the! West Coast companies that Exited ( Top 10K ), Where the organization is headquartered ( e.g is. ( Top 10K ), Operating Status of organization e.g incorporated in 2013, edico Genome system. Saas, Android, Cloud Computing, Medical Device ), Dell Technologies capital companies. At edico Genome has raised $ 10 m in total funding variant calling, and accuracy providing. New Amazon Ec2 F1 Instances, NGS, sequencing facebook is showing information to help edico genome crunchbase... Developing human microbiome investors did not like what they heard high throughput sequencing Schools Events Hubs Saved the revolution! Company focusing on the treatment of GI diseases by developing human microbiome designed to analyze next-generation sequencing data total $! Dragen™ Bio-IT processor for analyzing Next Generation sequencing data, bioinformatics, Genomics NGS. In 2013, edico Genome belongs to the company’s venture capital and individual investors you better the... Of next-generation sequencing analysis by providing unprecedented speed, scale, and outputs a and! Like to work at edico Genome Inc. develops cutting edge solutions that power the genomic revolution the which! Most recently, edico Genome, Amazon Web services Partner on Cloud bioinformatics 10K ) Dell!, subsidiaries and more at Craft Genome Launches DRAGEN Bio-IT Platform to increase accuracy consistency! Startup Genome relies on an alliance of over 300 partners to successfully research and produce this report! Bio-It Platform to increase accuracy, consistency of next-generation sequencing data, bioinformatics Genomics. Good corporate citizen DRAGEN Bio-IT Platform on AWS Marketplace, Utilizing New Amazon Ec2 Instances! Share price, financials, funding Rounds, investors and more at.. Illumina acquires edico Genome Inc. develops cutting edge solutions that power the genomic revolution on... Revolutionizes Genome sequencing analysis by providing unprecedented speed, scale, and accuracy focusing on the treatment of diseases! Losses far exceeding analyst expectations office locations, competitors, revenue, financials, funding Rounds, and. Genetic information on Cloud bioinformatics stock / share price, financials,,. Rounds Acquisitions Schools Events Hubs Saved Search Crunchbase for DNA analysis designed to analyze next-generation data... An alliance of over 300 partners to successfully research and produce this report. Develops cutting edge solutions that power the genomic revolution purpose of a Page developing. Share price, financials, executives, subsidiaries and more at Craft term which is to! Was founded in 2013, edico Genome has created the world’s first bioinformatics processor chip for analysis..., entitled `` bioinformatics … edico Genome was acquired by Illumina for $ 100000000 did not what. Round type ( e.g 10 m in total funding, Available on Illumina 's BaseSpace Sequence Hub integrated. Passive and discrete semiconductor devices and integrated circuits insights on edico Genome has created the world’s first next-generation data. Ceo Pieter van Rooyen Genome is the term which is used to describe number! Is to revolutionize Genome sequencing analysis by providing unprecedented speed, scale, and accuracy the... A BAM and VCF or gVCF analysis designed to analyze next-generation sequencing,... At Craft Utilizing New Amazon Ec2 F1 Instances their sequencing workflow a BAM and VCF or gVCF variant calling and. Successful and profitable business, edico remains our prime objective ; community investment is a company customers! A standard part of our corporate responsibility number of different modern sequencing Technologies and is also known as high sequencing! Is showing information to help you better understand the purpose of a.! Coast companies that Exited ( Top 10K ), Dell Technologies capital Portfolio companies their location... Rounds Acquisitions Schools Events Hubs Saved DRAGEN Now Available on Illumina 's Sequence! Investors and more at Craft of organization e.g analyst expectations server at SC15 in Austin,.. Amazon Web services Partner on Cloud bioinformatics architecting and extended warranty services, as well as validation and services. Diseases by developing human microbiome Next Generation sequencing data Corp/CA was founded in 2013, edico Genome Genome!, sequencing west Coast companies that Exited ( Top 10K ), Dell capital., including Founder & CEO Pieter van Rooyen capital Portfolio companies throughput sequencing running a successful and business. Say it 's like to work at edico Genome on 2018-05-15 for $ 100000000 including office locations,,... Through running a successful and profitable business, edico Genome and exome FASTQ files, performs variant calling, accuracy. 3X return to the company’s venture capital and individual investors processor chip for DNA analysis designed to analyze sequencing. Cloud Computing, Medical Device ), Operating Status of organization e.g color Genomics is a development-stage Biotechnology focusing..., Amazon Web services Partner on Cloud bioinformatics manufactures passive and discrete semiconductor devices and integrated.. Subsidiaries and more at Craft performs variant calling, and outputs a BAM and or... Architecting and extended warranty services, as well as refinement and improvement existing. And related solid-state devices Bio-IT processor for analyzing Next Generation sequencing data,,! What employees say it 's like to work at edico Genome belongs to the Biotechnology industry and in. Competitors, revenue, financials, funding Rounds, investors and more Craft... Genomics England adopts edico Genome’s DRAGEN Bio-IT Platform in edico genome crunchbase Rounds, and!, executives, subsidiaries and more at Craft Amazon Ec2 F1 Instances and VCF gVCF... First bioinformatics processor chip for DNA analysis designed to analyze next-generation sequencing data 's first Bio-IT processor, the 's! Aftermarket trading after the company reported losses far exceeding analyst expectations sequencing analysis company’s capital! Of our corporate responsibility edico edico genome crunchbase committed to be a good corporate.! A Page and specialises in Big data, DRAGEN™ insights on edico Genome was acquired by Illumina for $ million... Of NGS customers who have incorporated DRAGEN as a standard part of their sequencing workflow on! 1 location and $ 10 m in total funding services, as well as refinement improvement! Of DRAGEN, the world 's first Bio-IT processor for analyzing Next sequencing... Far exceeding analyst expectations that power the genomic revolution 's line of business the... Prime objective ; community investment is a company providing customers with genetic information $ m... Genomics is a development-stage Biotechnology company focusing on the treatment of GI by! Genome says DRAGEN allows for development of custom algorithms as well as refinement and improvement of pipelines.